Canada markets closed

Invitae Corporation (NVTA)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.5743-0.0193 (-3.25%)
At close: 03:59PM EST
0.5745 +0.00 (+0.03%)
After hours: 04:07PM EST

Invitae Corporation

1400 16th Street
San Francisco, CA 94103
United States
415 374 7782

IndustryDiagnostics & Research
Full Time Employees1,700

Key Executives

NameTitlePayExercisedYear Born
Dr. Randal W. Scott Ph.D.Co-Founder & Chairman of the Board50kN/A1958
Mr. Kenneth D. KnightPresident, CEO & Director1.4MN/A1961
Mr. Thomas R. BridaGeneral Counsel, Chief Compliance Officer & Secretary776.72kN/A1971
Dr. Robert L. Nussbaum M.D.Chief Medical Officer751.95kN/A1950
Ms. Ana J. SchrankChief Accounting Officer & CFON/AN/A1966
Dr. David B. Sholehvar M.D.Chief Operating OfficerN/AN/A1968
Ms. Hoki LukHead of Investor Relations and Capital MarketsN/AN/A1976
Ms. Shelly D. GuyerChief Sustainability Officer430.44kN/A1960
Ms. Desarie FrenchChief Talent OfficerN/AN/AN/A
Dr. W. Michael Korn M.D.Chief Medical OfficerN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Corporate Governance

Invitae Corporation’s ISS Governance QualityScore as of December 1, 2023 is 9. The pillar scores are Audit: 4; Board: 10; Shareholder Rights: 7; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.